Fitzpatrick Veronica, Erwin Kim, Rivelli Anne, Shields Maureen, Delfinado Leah, Cabiya Marie, Wennerberg Karen
Advocate Aurora Research Institute, Downers Grove, IL, USA.
Advocate Aurora Health; Downers Grove, IL, Milwaukee, WI, USA.
PEC Innov. 2023 Feb 15;2:100136. doi: 10.1016/j.pecinn.2023.100136. eCollection 2023 Dec.
The objective of the CONTINUE study is to gather preliminary data on the potential impact of implementing a "Cost Tool" in routine obstetrics (OB) care. It is hypothesized that by providing prenatal patients with an ability to forecast their care plan, they would be better able to anticipate and plan for the costs associated with their prenatal care.
Pilot data from interviews and surveys were collected from 71 prenatal patients across three clinics throughout Chicago, IL.
As compared to privately insured prenatal patients, prenatal patients with public insurance reported the most benefit in Cost Tool use. Specifically, that the Cost Tool helped to navigate insurance more effectively (OR 4.49, p=0.0254), see the "Big Picture" and link it to the family budget (OR 4.25, p=0.0099), and make the financial tradeoffs needed to get through pregnancy (OR 5.50, p=0.0305).
The CONTINUE study provides preliminary signals of the Cost Tool's potential to help publicly insured prenatal patients better navigate the costs associated with their care plan.
The CONTINUE study contributes valuable preliminary data about the utility of a cost tool in routine OB care, especially as it may benefit low-income prenatal patients navigate prenatal care better.
CONTINUE研究的目的是收集关于在常规产科护理中实施“成本工具”的潜在影响的初步数据。假设通过为产前患者提供预测其护理计划的能力，他们将能够更好地预测和规划与其产前护理相关的成本。
从伊利诺伊州芝加哥市三家诊所的71名产前患者那里收集了访谈和调查的试点数据。
与私人保险的产前患者相比，公共保险的产前患者报告使用成本工具的受益最大。具体而言，成本工具有助于更有效地处理保险事宜（比值比4.49，p = 0.0254），了解“全局”并将其与家庭预算联系起来（比值比4.25，p = 0.0099），以及做出度过孕期所需的财务权衡（比值比5.50，p = 0.0305）。
CONTINUE研究提供了初步迹象，表明成本工具有可能帮助公共保险的产前患者更好地应对与其护理计划相关的成本。
CONTINUE研究提供了关于成本工具在常规产科护理中的效用的宝贵初步数据，特别是因为它可能有助于低收入产前患者更好地应对产前护理。
